583 related articles for article (PubMed ID: 28786352)
1. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
[TBL] [Abstract][Full Text] [Related]
2. Vesicular Systems Containing Curcumin and Their Applications in Respiratory Disorders - A Mini Review.
Chellappan DK; Hansbro PM; Dua K; Hsu A; Gupta G; Ng ZY; Wong JY; Chellian J; Panneerselvam J
Pharm Nanotechnol; 2017; 5(4):250-254. PubMed ID: 28786351
[TBL] [Abstract][Full Text] [Related]
3. Connecting the dots in drug delivery: A tour d'horizon of chitosan-based nanocarriers system.
Pramanik S; Sali V
Int J Biol Macromol; 2021 Feb; 169():103-121. PubMed ID: 33338522
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
Islam N; Ferro V
Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
[TBL] [Abstract][Full Text] [Related]
5. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
6. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.
Chaudhury A; Das S
AAPS PharmSciTech; 2011 Mar; 12(1):10-20. PubMed ID: 21153572
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of therapeutic proteins based on zwitterionic chitosan-based nanocarriers for treatment on bleomycin-induced pulmonary fibrosis.
Zhang G; Mo S; Fang B; Zeng R; Wang J; Tu M; Zhao J
Int J Biol Macromol; 2019 Jul; 133():58-66. PubMed ID: 30981773
[TBL] [Abstract][Full Text] [Related]
8. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N
Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555
[TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.
Rajitha P; Gopinath D; Biswas R; Sabitha M; Jayakumar R
Expert Opin Drug Deliv; 2016 Aug; 13(8):1177-94. PubMed ID: 27087148
[TBL] [Abstract][Full Text] [Related]
10. Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose.
Zhang L; Yang L; Zhang X; Jiaqi L; Fan L; Beck-Broichsitter M; Zhang X; Muenster U; Wang X; Zhao J; Zhang Y; Mao S
J Control Release; 2018 Aug; 283():163-174. PubMed ID: 29842919
[TBL] [Abstract][Full Text] [Related]
11. Chitosan and its derivatives as vehicles for drug delivery.
Huang G; Liu Y; Chen L
Drug Deliv; 2017; 24(sup1):108-113. PubMed ID: 29124981
[TBL] [Abstract][Full Text] [Related]
12. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics.
Jhaveri J; Raichura Z; Khan T; Momin M; Omri A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33430478
[TBL] [Abstract][Full Text] [Related]
13. Chitosan nanopolymers: An overview of drug delivery against cancer.
Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
[TBL] [Abstract][Full Text] [Related]
14. Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review.
Kriplani P; Guarve K
Recent Pat Anticancer Drug Discov; 2021; 16(2):249-257. PubMed ID: 33563157
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research.
Naskar S; Koutsu K; Sharma S
J Drug Target; 2019 Apr; 27(4):379-393. PubMed ID: 30103626
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
17. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary drug delivery applications of natural polysaccharide polymer derived nano/micro-carrier systems: A review.
Balde A; Kim SK; Benjakul S; Nazeer RA
Int J Biol Macromol; 2022 Nov; 220():1464-1479. PubMed ID: 36116588
[TBL] [Abstract][Full Text] [Related]
19. Advances in chitosan-based nanoparticles for oncotherapy.
Zhang E; Xing R; Liu S; Qin Y; Li K; Li P
Carbohydr Polym; 2019 Oct; 222():115004. PubMed ID: 31320066
[TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
